1. Home
  2. GDRX vs FTRE Comparison

GDRX vs FTRE Comparison

Compare GDRX & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoodRx Holdings Inc.

GDRX

GoodRx Holdings Inc.

HOLD

Current Price

$3.45

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$18.39

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDRX
FTRE
Founded
2011
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
GDRX
FTRE
Price
$3.45
$18.39
Analyst Decision
Buy
Buy
Analyst Count
9
9
Target Price
$3.66
$14.06
AVG Volume (30 Days)
1.7M
1.7M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
125.00
N/A
EPS
0.03
N/A
Revenue
$796,853,000.00
$2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.38
$3.09
P/E Ratio
$118.67
N/A
Revenue Growth
0.57
1.00
52 Week Low
$1.77
$8.22
52 Week High
$5.61
$21.39

Technical Indicators

Market Signals
Indicator
GDRX
FTRE
Relative Strength Index (RSI) 53.59 50.74
Support Level $2.54 $16.92
Resistance Level $3.89 $21.39
Average True Range (ATR) 0.21 1.06
MACD -0.02 -0.13
Stochastic Oscillator 46.10 51.48

Price Performance

Historical Comparison
GDRX
FTRE

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Share on Social Networks: